These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 16278399)
1. Patupilone induced vascular disruption in orthotopic rodent tumor models detected by magnetic resonance imaging and interstitial fluid pressure. Ferretti S; Allegrini PR; O'Reilly T; Schnell C; Stumm M; Wartmann M; Wood J; McSheehy PM Clin Cancer Res; 2005 Nov; 11(21):7773-84. PubMed ID: 16278399 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo. O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895 [TBL] [Abstract][Full Text] [Related]
3. Quantified tumor t1 is a generic early-response imaging biomarker for chemotherapy reflecting cell viability. McSheehy PM; Weidensteiner C; Cannet C; Ferretti S; Laurent D; Ruetz S; Stumm M; Allegrini PR Clin Cancer Res; 2010 Jan; 16(1):212-25. PubMed ID: 20008843 [TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast-enhanced magnetic resonance imaging of tumor interstitial fluid pressure. Gulliksrud K; Brurberg KG; Rofstad EK Radiother Oncol; 2009 Apr; 91(1):107-13. PubMed ID: 18973959 [TBL] [Abstract][Full Text] [Related]
5. Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastases. Lee L; Sharma S; Morgan B; Allegrini P; Schnell C; Brueggen J; Cozens R; Horsfield M; Guenther C; Steward WP; Drevs J; Lebwohl D; Wood J; McSheehy PM Cancer Chemother Pharmacol; 2006 Jun; 57(6):761-71. PubMed ID: 16172907 [TBL] [Abstract][Full Text] [Related]
6. Patupilone (epothilone B, EPO906) inhibits growth and metastasis of experimental prostate tumors in vivo. O'Reilly T; McSheehy PM; Wenger F; Hattenberger M; Muller M; Vaxelaire J; Altmann KH; Wartmann M Prostate; 2005 Nov; 65(3):231-40. PubMed ID: 15948135 [TBL] [Abstract][Full Text] [Related]
8. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging. Wilmes LJ; Pallavicini MG; Fleming LM; Gibbs J; Wang D; Li KL; Partridge SC; Henry RG; Shalinsky DR; Hu-Lowe D; Park JW; McShane TM; Lu Y; Brasch RC; Hylton NM Magn Reson Imaging; 2007 Apr; 25(3):319-27. PubMed ID: 17371720 [TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging measurements of the response of murine and human tumors to the vascular-targeting agent ZD6126. Evelhoch JL; LoRusso PM; He Z; DelProposto Z; Polin L; Corbett TH; Langmuir P; Wheeler C; Stone A; Leadbetter J; Ryan AJ; Blakey DC; Waterton JC Clin Cancer Res; 2004 Jun; 10(11):3650-7. PubMed ID: 15173071 [TBL] [Abstract][Full Text] [Related]
10. Treatment of rodent liver tumor with combretastatin a4 phosphate: noninvasive therapeutic evaluation using multiparametric magnetic resonance imaging in correlation with microangiography and histology. Wang H; Sun X; Chen F; De Keyzer F; Yu J; Landuyt W; Vandecaveye V; Peeters R; Bosmans H; Hermans R; Marchal G; Ni Y Invest Radiol; 2009 Jan; 44(1):44-53. PubMed ID: 19034028 [TBL] [Abstract][Full Text] [Related]
11. Noninvasive magnetic resonance imaging of transport and interstitial fluid pressure in ectopic human lung tumors. Hassid Y; Furman-Haran E; Margalit R; Eilam R; Degani H Cancer Res; 2006 Apr; 66(8):4159-66. PubMed ID: 16618737 [TBL] [Abstract][Full Text] [Related]
12. Associations between radiocurability and interstitial fluid pressure in human tumor xenografts without hypoxic tissue. Rofstad EK; Ruud EB; Mathiesen B; Galappathi K Clin Cancer Res; 2010 Feb; 16(3):936-45. PubMed ID: 20103667 [TBL] [Abstract][Full Text] [Related]
13. Role of the microenvironment for radiosensitization by patupilone. Bley CR; Jochum W; Orlowski K; Furmanova P; Vuong V; McSheehy PM; Pruschy M Clin Cancer Res; 2009 Feb; 15(4):1335-42. PubMed ID: 19228735 [TBL] [Abstract][Full Text] [Related]
14. Effects of the vascular disrupting agent ZD6126 on interstitial fluid pressure and cell survival in tumors. Skliarenko JV; Lunt SJ; Gordon ML; Vitkin A; Milosevic M; Hill RP Cancer Res; 2006 Feb; 66(4):2074-80. PubMed ID: 16489007 [TBL] [Abstract][Full Text] [Related]
15. Correlations between dynamic contrast-enhanced magnetic resonance imaging-derived measures of tumor microvasculature and interstitial fluid pressure in patients with cervical cancer. Haider MA; Sitartchouk I; Roberts TP; Fyles A; Hashmi AT; Milosevic M J Magn Reson Imaging; 2007 Jan; 25(1):153-9. PubMed ID: 17173303 [TBL] [Abstract][Full Text] [Related]
16. Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma. Rosen MA; Schnall MD Clin Cancer Res; 2007 Jan; 13(2 Pt 2):770s-776s. PubMed ID: 17255308 [TBL] [Abstract][Full Text] [Related]
17. PTK787/ZK222584, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor, reduces uptake of the contrast agent GdDOTA by murine orthotopic B16/BL6 melanoma tumours and inhibits their growth in vivo. Rudin M; McSheehy PM; Allegrini PR; Rausch M; Baumann D; Becquet M; Brecht K; Brueggen J; Ferretti S; Schaeffer F; Schnell C; Wood J NMR Biomed; 2005 Aug; 18(5):308-21. PubMed ID: 15918178 [TBL] [Abstract][Full Text] [Related]